These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1649139)

  • 1. A novel recombinant tumor necrosis factor-alpha mutant with increased anti-tumor activity and lower toxicity.
    Nakamura S; Kato A; Masegi T; Fukuoka M; Kitai K; Ogawa H; Ichikawa Y; Maeda M; Watanabe N; Kohgo Y
    Int J Cancer; 1991 Jul; 48(5):744-8. PubMed ID: 1649139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a novel human tumor necrosis factor-alpha mutant with increased cytotoxic activity.
    Masegi T; Kato A; Kitai K; Fukuoka M; Ogawa H; Ichikawa Y; Nakamura S; Watanabe N; Niitsu Y
    Jpn J Cancer Res; 1995 Jan; 86(1):72-80. PubMed ID: 7737913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between novel tumor necrosis factor-alpha mutants and receptors on tumor and normal cells.
    Nakamura S; Masegi T; Fukuoka M; Kitai K; Kato A; Ichikawa Y; Watanabe N; Niitsu Y
    Agric Biol Chem; 1991 Jan; 55(1):53-7. PubMed ID: 1369315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mutated human tumor necrosis factor-alpha improves the therapeutic index in vitro and in vivo.
    Yan Z; Zhao N; Wang Z; Li B; Bao C; Shi J; Han W; Zhang Y
    Cytotherapy; 2006; 8(4):415-23. PubMed ID: 16923618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of a novel chimera tumor necrosis factor (TNF-STH) constructed by connecting rTNF-S with thymosin beta 4 against murine syngeneic tumors.
    Noguchi K; Inagawa H; Tsuji Y; Morikawa A; Mizuno D; Soma G
    J Immunother (1991); 1991 Apr; 10(2):105-11. PubMed ID: 2043590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of tumor necrosis factor alpha conjugated with divinyl ether and maleic anhydride copolymer on solid tumors in mice.
    Kaneda Y; Yamamoto Y; Kamada H; Tsunoda S; Tsutsumi Y; Hirano T; Mayumi T
    Cancer Res; 1998 Jan; 58(2):290-5. PubMed ID: 9443407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antitumor function of tumor necrosis factor (TNF), I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity.
    Havell EA; Fiers W; North RJ
    J Exp Med; 1988 Mar; 167(3):1067-85. PubMed ID: 3351434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor pretargeting with avidin improves the therapeutic index of biotinylated tumor necrosis factor alpha in mouse models.
    Gasparri A; Moro M; Curnis F; Sacchi A; Pagano S; Veglia F; Casorati G; Siccardi AG; Dellabona P; Corti A
    Cancer Res; 1999 Jun; 59(12):2917-23. PubMed ID: 10383155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human tumor necrosis factor-alpha mutant RGD-V29 (F4614) shows potent antitumor activity and reduced toxicity against human tumor xenografted nude mice.
    Kuroda K; Miyata K; Fujita F; Koike M; Fujita M; Nomura M; Nakagawa S; Tsutsumi Y; Kawagoe T; Mitsuishi Y; Mayumi T
    Cancer Lett; 2000 Oct; 159(1):33-41. PubMed ID: 10974403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the biological activity of TNF alpha and TNF beta correlate with their different abilities for binding to the target cells.
    Kircheis R; Milleck J; Korobko VG; Shingarova LN; Schmidt HE
    Eur Cytokine Netw; 1992; 3(4):381-90. PubMed ID: 1330049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of cytotoxicity of tumor necrosis factor (TNF) by increase in basicity of its N-terminal region.
    Soma G; Kitahara N; Tsuji Y; Kato M; Oshima H; Gatanaga T; Inagawa H; Noguchi K; Tanabe Y; Mizuno D
    Biochem Biophys Res Commun; 1987 Oct; 148(2):629-35. PubMed ID: 3318824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functionalization of tumor necrosis factor-alpha using phage display technique and PEGylation improves its antitumor therapeutic window.
    Shibata H; Yoshioka Y; Ikemizu S; Kobayashi K; Yamamoto Y; Mukai Y; Okamoto T; Taniai M; Kawamura M; Abe Y; Nakagawa S; Hayakawa T; Nagata S; Yamagata Y; Mayumi T; Kamada H; Tsutsumi Y
    Clin Cancer Res; 2004 Dec; 10(24):8293-300. PubMed ID: 15623605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
    Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J
    Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-directed mutational analysis of human tumor necrosis factor-alpha receptor binding site and structure-functional relationship.
    Zhang XM; Weber I; Chen MJ
    J Biol Chem; 1992 Nov; 267(33):24069-75. PubMed ID: 1331108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mode of antitumor action of recombinant human tumor necrosis factor on the sarcoma Meth A transplanted in the mouse.
    Miyazaki H; Iida M; Matsunaga Y; Fujii T; Nambu K; Amejima H; Oh-e Y; Furukawa H; Matsui Y; Sohmura Y
    Biotherapy; 1988; 1(1):47-57. PubMed ID: 3275291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of differentiation of human monoblastic and myeloblastic leukemia cell lines by TNF muteins.
    Kamijo R; Takeda K; Nagumo M; Konno K; Hasegawa A; Inaka K; Ikehara M
    Biochem Biophys Res Commun; 1989 Apr; 160(2):820-7. PubMed ID: 2541714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of novel tumor necrosis factor-alpha mutants with reduced toxicity and higher cytotoxicity on human tumor cells.
    Liu H; Lu F; Chen J; Ren H; Chen C
    Sci China C Life Sci; 2003 Feb; 46(1):1-9. PubMed ID: 20213356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the in vitro and in vivo species preference of human and murine tumor necrosis factor-alpha.
    Kramer SM; Aggarwal BB; Eessalu TE; McCabe SM; Ferraiolo BL; Figari IS; Palladino MA
    Cancer Res; 1988 Feb; 48(4):920-5. PubMed ID: 2827889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor as an adjunct to fractionated radiotherapy in the treatment of murine tumors.
    Nishiguchi I; Willingham V; Milas L
    Int J Radiat Oncol Biol Phys; 1990 Mar; 18(3):555-8. PubMed ID: 2318687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular production of human tumor necrosis factor-alpha by Escherichia coli using a chemically-synthesized gene.
    Nakamura S; Masegi T; Kitai K; Ichikawa Y; Kudo T; Aono R; Horikoshi K
    Agric Biol Chem; 1990 Dec; 54(12):3241-50. PubMed ID: 1368641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.